These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 16990649)

  • 41. Mammary radioiodine accumulation due to functional sodium iodide symporter expression in a benign fibroadenoma.
    Berger F; Unterholzner S; Diebold J; Knesewitsch P; Hahn K; Spitzweg C
    Biochem Biophys Res Commun; 2006 Nov; 349(4):1258-63. PubMed ID: 16982034
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Regulation of the sodium/iodide symporter by retinoids--a review.
    Schmutzler C
    Exp Clin Endocrinol Diabetes; 2001; 109(1):41-4. PubMed ID: 11573138
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A Carboxy-Terminal Monoleucine-Based Motif Participates in the Basolateral Targeting of the Na+/I- Symporter.
    Martín M; Modenutti CP; Peyret V; Geysels RC; Darrouzet E; Pourcher T; Masini-Repiso AM; Martí MA; Carrasco N; Nicola JP
    Endocrinology; 2019 Jan; 160(1):156-168. PubMed ID: 30496374
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The Na+/I- symporter (NIS): mechanism and medical impact.
    Portulano C; Paroder-Belenitsky M; Carrasco N
    Endocr Rev; 2014 Feb; 35(1):106-49. PubMed ID: 24311738
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Sodium iodide symporter in physiology and diseases -- the current state of knowledge].
    Wolny M; Syrenicz A
    Endokrynol Pol; 2007; 58(6):512-21. PubMed ID: 18205108
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Targeting Novel Sodium Iodide Symporter Interactors ADP-Ribosylation Factor 4 and Valosin-Containing Protein Enhances Radioiodine Uptake.
    Fletcher A; Read ML; Thornton CEM; Larner DP; Poole VL; Brookes K; Nieto HR; Alshahrani M; Thompson RJ; Lavery GG; Landa I; Fagin JA; Campbell MJ; Boelaert K; Turnell AS; Smith VE; McCabe CJ
    Cancer Res; 2020 Jan; 80(1):102-115. PubMed ID: 31672844
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Different expression of sodium-iodide importer (NIS) between lactating breast and thyroid tissues may be due to structural difference of thyroid-stimulating hormone receptor (TSHR).
    Shi XZ; Xue L; Jin X; Xu P; Jia S; Shen HM
    J Endocrinol Invest; 2017 Jan; 40(1):41-48. PubMed ID: 27531173
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The sodium-iodide symporter.
    Baker CH; Morris JC
    Curr Drug Targets Immune Endocr Metabol Disord; 2004 Sep; 4(3):167-74. PubMed ID: 15379719
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Expression of the sodium iodide symporter and thyroglobulin genes are reduced in papillary thyroid cancer.
    Ringel MD; Anderson J; Souza SL; Burch HB; Tambascia M; Shriver CD; Tuttle RM
    Mod Pathol; 2001 Apr; 14(4):289-96. PubMed ID: 11301345
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Immunohistochemical profile of the sodium/iodide symporter in thyroid, breast, and other carcinomas using high density tissue microarrays and conventional sections.
    Wapnir IL; van de Rijn M; Nowels K; Amenta PS; Walton K; Montgomery K; Greco RS; Dohán O; Carrasco N
    J Clin Endocrinol Metab; 2003 Apr; 88(4):1880-8. PubMed ID: 12679487
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Increased expression of the sodium/iodide symporter in papillary thyroid carcinomas.
    Saito T; Endo T; Kawaguchi A; Ikeda M; Katoh R; Kawaoi A; Muramatsu A; Onaya T
    J Clin Invest; 1998 Apr; 101(7):1296-300. PubMed ID: 9525971
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The BRAFV600E oncogene induces transforming growth factor beta secretion leading to sodium iodide symporter repression and increased malignancy in thyroid cancer.
    Riesco-Eizaguirre G; Rodríguez I; De la Vieja A; Costamagna E; Carrasco N; Nistal M; Santisteban P
    Cancer Res; 2009 Nov; 69(21):8317-25. PubMed ID: 19861538
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Immunoanalysis indicates that the sodium iodide symporter is not overexpressed in intracellular compartments in thyroid and breast cancers.
    Peyrottes I; Navarro V; Ondo-Mendez A; Marcellin D; Bellanger L; Marsault R; Lindenthal S; Ettore F; Darcourt J; Pourcher T
    Eur J Endocrinol; 2009 Feb; 160(2):215-25. PubMed ID: 19029227
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The rat sodium iodide symporter gene permits more effective radioisotope concentration than the human sodium iodide symporter gene in human and rodent cancer cells.
    Heltemes LM; Hagan CR; Mitrofanova EE; Panchal RG; Guo J; Link CJ
    Cancer Gene Ther; 2003 Jan; 10(1):14-22. PubMed ID: 12489024
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [The sodium-iodide-symporter (NIS): function, regulation and clinical importance].
    Köhrle J
    Z Arztl Fortbild Qualitatssich; 1999 Apr; 93 Suppl 1():17-22. PubMed ID: 10355044
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Journey of the iodide transporter NIS: from its molecular identification to its clinical role in cancer.
    Riedel C; Dohán O; De la Vieja A; Ginter CS; Carrasco N
    Trends Biochem Sci; 2001 Aug; 26(8):490-6. PubMed ID: 11504625
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Stimulation of retinoic acid-induced functional sodium iodide symporter (NIS) expression and cytotoxicity of ¹³¹I by carbamazepine in breast cancer cells.
    Willhauck MJ; O Kane DJ; Wunderlich N; Göke B; Spitzweg C
    Breast Cancer Res Treat; 2011 Jan; 125(2):377-86. PubMed ID: 20300827
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Telomerase-driven expression of the sodium iodide symporter (NIS) for in vivo radioiodide treatment of cancer: a new broad-spectrum NIS-mediated antitumor approach.
    Riesco-Eizaguirre G; De la Vieja A; Rodríguez I; Miranda S; Martín-Duque P; Vassaux G; Santisteban P
    J Clin Endocrinol Metab; 2011 Sep; 96(9):E1435-43. PubMed ID: 21697253
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Radiation-induced thyroid stunning: differential effects of (123)I, (131)I, (99m)Tc, and (211)At on iodide transport and NIS mRNA expression in cultured thyroid cells.
    Lundh C; Lindencrona U; Postgård P; Carlsson T; Nilsson M; Forssell-Aronsson E
    J Nucl Med; 2009 Jul; 50(7):1161-7. PubMed ID: 19525464
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The Na/I symporter (NIS): imaging and therapeutic applications.
    Dadachova E; Carrasco N
    Semin Nucl Med; 2004 Jan; 34(1):23-31. PubMed ID: 14735456
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.